In drie stappen
het juiste contact

50 betrokken LIOF’ers helpen jouw bedrijf groeien met advies, een waardevol netwerk en financiering op weg naar een slimmer, duurzamer en gezonder Limburg.

12 januari 2023

Icos Capital, Brightlands Ventures and LIOF exit health food ingredient company BioActor

Icos Capital, Brightlands Ventures and LIOF exit health food ingredient company BioActor, leader in the development and commercialisation of clinically proven natural active ingredients for leading food brands to French corporate Solabia Group.

Founded in 2011, BioActor is an innovation leader in the development and commercialisation of clinically evaluated polyphenols extracted from edible plants and fruits and used by leading food supplement brands worldwide. Thanks to an in-house clinical research team with direct access to a stateof-
the-art clinical research facility and a genuine passion for innovation, BioActor’s health ingredients are all first-in-class, offering supplement brands the opportunity to develop unique solutions to consumers worldwide. BioActor currently exports to more than 20 countries worldwide, serving leading
brands across the nutrition and supplement industries.

Solabia is already present in the nutrition segment through original ingredients recognized for their health benefits. This strategic investment will allow Solabia to benefit from a wider range of ingredients and from BioActor’s expertise, strengthening its nutrition division positioning on this fast-growing market, as customers increasingly look for high quality active ingredients that combine naturality with proofs of efficacy.

Icos Capital led the initial series A investment in BioActor B.V. in 2011 and, together with co-investors Brightlands Venture Partners and Nedermaas Ventures (LIOF), supported the company on its journey to create value by sourcing health food ingredient innovations from European R&D universities and
technology institutes and systematically working on validation, sourcing, processing, scaling up production, marketing and sales of multiple health food ingredients. Today, BioActor has 8 products in the markets globally.

Peter van Gelderen, Managing Partner at Icos Capital, stated:
“In a joined effort with Brightlands Venture Partners and LIOF we are proud to have supported the visionary founder and the team of BioActor to create a best in class platform to source, validate and bring to market innovative health food ingredients and supplements. We believe the foundations that have been created up to now, together with the expertise and market presence of Solabia going forward, will provide an excellent base for the next phase of the successful journey of BioActor. We thank all parties for making this successful exit happen and we wish the team all the best in realizing further ambitions.”

About BioActor
BioActor is an innovation leader in the development, and commercialisation of clinically evaluated polyphenols extracted from edible plants and fruits. Based at the Maastricht Health Campus at walking distance from the largest nutrition & health faculty of The Netherlands and the Maastricht University Medical Center, the Company has an in-house clinical research team with direct access a state-of-theart clinical research facility. Since its inception in 2011, BioActor has developed 8 branded health ingredients, supported by more than 20 clinical studies. The company currently exports its products to leading brands in more than 20 countries worldwide across the nutrition, food and beverages industries.
More information about BioActor can be found at:

Nieuws direct in jouw mailbox?

Contactgegevens opslaan (vcard)
Bel me terug
Bedankt, wij nemen zo snel mogelijk contact op.

LIOF nieuws

Altijd op de hoogte zijn van nieuwe ontwikkelingen, trends en events die interessant zijn voor ondernemend Limburg?